LPCN – lipocine inc. (US:NASDAQ)
Stock Stats
News
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session [Yahoo! Finance]
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Form 8-K Lipocine Inc. For: Nov 18
Form 8-K Lipocine Inc. For: Nov 07
Form 10-Q Lipocine Inc. For: Sep 30
Form 8-K Lipocine Inc. For: Nov 05
Form 8-K Lipocine Inc. For: Oct 28
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.